The U.S. Food and Drug Administration (FDA) has decided Cipro and its class of antibiotics known as fluoroquinolones will now bear a "black box" after reports confirmed that the drugs increase the risk of tendinitis and tendon rupture.
The federal agency said that the warning on the drug is necessary to ensure that the drugs' benefits outweigh the risks. It is also requiring the manufacturers to provide a medication guide to patients about the potential side effects of tendon rupture